HAC (Russian)
RSCI (Russian)
EBSCO
DOI (USA)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services

SARCOMATOID CARCINOMA: THE FEATURES OF DIAGNOSIS AND PREOPERATIVE PLANNING

DOI: https://doi.org/10.29296/25877305-2018-05-01
Download full text PDF
Issue: 
5
Year: 
2018

E. Shpot(1), D. med. Sc., MD, PhD; A. Proskura(1); M. Yurova(2); D. Fiev(1), D. med. Sc., MD, PhD; S. Khokhlachev(3); Yu. Lerner(2) 1-Department and Clinic of Urology, Research Institute of Uronephrology and Human Reproductive Health, I.M. Sechenov First Moscow State Medical University (Sechenov University) 2-I.M. Sechenov First Moscow State Medical University (Sechenov University) 3-Central Research Institute of Dentistry, Moscow

Sarcomatoid transformation is possible in 10-20% cases of renal cell carcinoma. The favorable outcome of surgical treatment in a patient is largely provided by the virtual planning of an operation, by using 3-dimensional (3D) models – multiplanar images obtained by contrast-enhanced multispiral computed tomography (MSCT)

Keywords: 
surgery
oncology
3D
MSCT
invasion to the liver
kidney cancer
sarcomatoid carcinoma



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Andreeva Ju.Ju., Moskvina L.V., Zavalishina L.E. i dr. Opuholi pochki. Morfologichekskaja diagnostika i genetika. Rukovodstvo. Pod red. Ju.Ju. Andreevoj, G.A. Franka / M.: RMAPO, 2011; 66 s.
  2. Alekseev B.Ja., Volkova M.I., Kalpinskij A.S. i dr. Klinicheskie rekomendatsii po diagnostike i lecheniju raka pochki. AOR, 2014.
  3. Solodkij V.A., Pavlov A.Ju., Garmash S.V. i dr. Klinicheskij sluchaj effektivnogo hirurgicheskogo lechenija patsientki s IV stadiej raka pochki s invaziej v pechen' s 50% sarkomatoidnym komponentom pochechnokletochnogo raka bez otdalennogo metastazirovanija // Onkourologija. – 2016; 12 (4): 142–5.
  4. Alekseev B.Ja., Anzhiganova Ju.V., Lykov A.V. i dr. Osobennosti diagnostiki i lechenija raka pochki v Rossii: predvaritel'nye rezul'taty mnogotsentrovogo kooperirovannogo issledovanija // Onkourologija. – 2012; 3: 24–30.
  5. Nosov D.A., Vorob'ev N.A., Gladkov O.A. i dr. Prakticheskie rekomendatsii po diagnostike i lecheniju pochechnokletochnogo raka // Zlokachestvennye opuholi. – 2016; 4 (Spetsvyp. 2): 333–7.
  6. Farrow G., Harrison E. Jr, Utz D. Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adults // Cancer. – 1968; 22: 545–63.
  7. Fuser D., Hedberg M., Dehner L. et al. Extensive Metastatic Sarcomatoid Renal Cell Carcinoma Evaluated by 18F-FDG PET/CT: a Case Report and Review of Literature // J. Kidney Cancer VHL. – 2018; 5 (1): 1–6.
  8. Wei S., Al-Saleem T. The Pathology and Molecular Genetics of Sarcomatoid Renal Cell Carcinoma: A Mini-Review // J. Kidney Cancer VHL. – 2017; 4 (2): 19–23. DOI: 10.15586/jkcvhl.2017.70.
  9. Kyriakopoulos C., Chittoria N., Choueiri T. et al. Outcome of patients with metastatic sarcomatoid renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium // Clin. Genitourin Cancer. – 2015; 13 (2): e79–85.
  10. Kush S. Renal Cell Carcinoma [cited 2017 June 24]. Available from: http://emedicine.medscape.com/article/281340-overview.
  11. Eble J. Renomedullary intestinel cell tumor. Glava iz Eble J., Sauter G., Epstein J. et al. World Health Organization: Pathology and genetics of tumours of the urinary system and male genital organs / Lyon, France: IARC Press, 2004.
  12. Shuch B., Amin A., Armstrong A. et al. Understanding pathologic variants of renal cell carcinoma: Distilling therapeutic opportunities from biologic complexity // Eur. Urol. – 2015; 67 (1): 85–97.
  13. Delahunt B., Egevad L., Montironi R. et al. International Society of Urological Pathology (ISUP) consensus conference on renal neoplasia: rationale and organization // Am. J. Surg. Pathol. – 2013; 37 (10): 1463–8.
  14. Bostwick D., Cheng L. Urologic surgical pathology / Philadelphia, PA, USA: Elsevier Health Sciences, 2008.
  15. Kuroda N., Toi M., Hiroi M. et al. Review of sarcomatoid renal cell carcinoma with focus on clinical and pathobiological aspects // Histol. Histopathol. – 2003; 18 (2): 551–5.
  16. Krishnan B., Truong L. Renal epithelial neoplasms: The diagnostic implications of electron microscopic study in 55 cases // Hum. Pathol. – 2002; 33 (1): 68–79.
  17. Srigley J., Delahunt B. Uncommon and recently described renal carcinomas // Mod. Pathol. – 2009; 22: 2–23.
  18. Chan J. Newly available antibodies with practical applications in surgical pathology // Int. J. Surg. Pathol. – 2013; 21: 553–72.
  19. Kim J., Kim T., Ahn H. et al. Differentiation of subtypes of renal cell carcinoma on helical CT scans // AJR Am. J. Roentgenol. – 2002; 178 (6): 1499–506.
  20. Quaia E., Bussani R., Cova M. et al. Radiologic-pathologic correlations of intratumoral tissue components in the most common solid and cystic renal tumors. Pictorial review // Eur. Radiol. – 2005; 15 (8): 1734–44.
  21. Zhang D., Zeng G., Zhang Y. et al. 3D reconstruction computed tomography scan in diagnosis of bilateral wilm's tumor with its embolus in right atrium // J. X-ray Sci. Technol. – 2016; 24 (5): 657–60.
  22. Reznek R. CT/MRI in staging renal cell carcinoma // Cancer Imaging. – 2004; 4 (Spec No A): 25–32.
  23. Linguraru M., Yao J., Gautam R. et al. Renal Tumor Quantification and Classification in Contrast-Enhanced Abdominal CT // Pattern Recognit. – 2009; 42 (6): 1149–61.
  24. Ng C., Wood C., Silverman P. et al. Renal cell carcinoma: diagnosis, staging, and surveillance // AJR Am. J. Roentgenol. – 2008; 191 (4): 1220–32.
  25. Silverman S., Leyendecker J., Amis E. Jr. What is the current role of CT urography and MR urography in the evaluation of the urinary tract? // Radiology. – 2009; 250 (2): 309–23.
  26. Peng N., Wang X., Zhang Z. et al. Diagnosis value of multi-slice spiral CT in renal trauma // J. X-ray Sci. Technol. – 2016; 24 (5): 649–55.
  27. Maiti A., Nemati-Shafaee M., Msaouel P. et al. Phase 2 trial of capecitabine, gemcitabine, and bevacizumab in sarcomatoid renal-cell carcinoma // Clin. Genitourin Cancer. – 2018; 16 (1): 47–57. DOI: 10.1016/j.clgc.2017.07.028.
  28. Joseph R., Millis S., Carballido E. et al. PD-1 and PD-L1 expression in renal cell carcinoma with sarcomatoid differentiation // Cancer Immunol. Res. – 2015; 3 (12): 1303–7.
  29. McDermott D., Sosman J., Sznol M. et al. Atezolizumab, an anti-programmed death-ligand 1 antibody, in metastatic renal cell carcinoma: Long-term safety, clinical activity, and immune correlates from a phase Ia study // J. Clin. Oncol. – 2016; 34: 833–42.
  30. Amin M., Corless C., Renshaw A. et al. Papillary (chromophil) renal cell carcinoma: histomorphologyc characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases // Am. J. Surg. Pathol. – 1997; 21: 621–35.
  31. Shuch B., Said J., La Rochelle J. et al. Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology – Is up-front resection indicated and, if not, is it avoidable? // J. Urol. – 2009; 182 (5): 2164–71.
  32. Shuch B., Bratslavsky G., Linehan W. et al. Sarcomatoid renal cell carcinoma: A comprehensive review of the biology and current treatment strategies // Oncologist. – 2012; 17: 46–54.
  33. Mian B., Bhadkamkar N., Slaton J. et al. Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma // J. Urol. – 2002; 167: 65–70.
  34. Kawata N., Hirakata H., Yuge H. et al. Cytoreductive surgery with liver-involved renal cell carcinoma // Intern. J. Urol.: Official J. Japan. Urol. Assoc. – 2000; 7 (10): 382–5.
  35. Zhang B., Thompson R., Lohse C. et al. A novel prognostic model for patients with sarcomatoid renal cell carcinoma // BJU Int. – 2015; 115 (3): 405–11.
  36. Li Y., Sun J., Zhang Y. et al. 3D reconstruction images of cone beam computed tomography in dental medicine application: A case study and mini-review // J. X-ray Sci. Technol. – 2016; 24 (5): 673–80.
  37. Chen L., Zeng X., Li S. et al. Evaluation of a large adrenal carcinoma with 3D reconstruction of computed tomography images: A case report and literature review // J. X-ray Sci. Technol. – 2016; 24 (5): 665–71.
  38. Yu Y., Li J., Guo L. et al. Bilateral duplex urinary collecting systems accompanied with horseshoe kidneys deformity and right renal ureteral calculi and hydronephrosis: Diagnosis in magnetic resonance urography // J. X-ray Sci. Technol. – 2017; 25 (4): 667–72. DOI: 10.3233/XST-17250.
  39. Zhang C., Li X., Mo C. et al. Benign mixed epithelial and stromal tumor of the kidney with inferior vena cava tumor thrombus: A rare case report and review of literature // J. X-ray Sci. Technol. – 2017; 25 (5): 831–7. DOI: 10.3233/XST-16245
  40. Radiology Assistant. Available from: http://www.radiologyassistant.nl/en/p571eea20ec282/kidney-solid-masses.html#in571eea2133bc7
  41. Margulis V., Sanchez-Ortiz R., Tamboli P. et al. Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management // Cancer. – 2007; 109 (10): 2025–30.
  42. Wong J., Whelan T., Morse M. Radical nephrectomy with en bloc resection of liver, diaphragm, and lung for locally invasive sarcomatoid renal cell carcinoma // Urology. – 2006; 68 (4): 890.e1–4.
  43. Bennett B., Selby R., Bahnson R. Surgical resection for management of renal cancer with hepatic involvement // J. Urol. – 1995; 154 (3): 972–4.
  44. Johnin K., Nakai O., Kataoka A. et al. Surgical management of renal cell carcinoma invading into the liver: radical nephrectomy en bloc with right hepatic lateral sector // Urology. – 2001; 57 (5): 975.
  45. Joyce D., Psutka S., Groeschl R. et al. Complications and Outcomes Associated With Surgical Management of Renal Cell Carcinoma Involving the Liver: A Matched Cohort Study // Urology. – 2017; 99: 155–61.
  46. Yoshimatsu M., Shirabe K., Nagao Y. et al. A safe combined nephrectomy and right lobectomy using the liver hanging maneuver for huge renal cell carcinoma directly invading the right lobe of the liver: report of a case // Surgery today. – 2014; 44 (9): 1778–8